Abstract
The recent implication of the cell death pathway, necroptosis, in innate immunity and a range of human pathologies has led to intense interest in the underlying molecular mechanism. Unlike the better-understood apoptosis pathway, necroptosis is a caspase-independent pathway that leads to cell lysis and release of immunogens downstream of death receptor and Toll-like receptor (TLR) ligation. Here we review the role of recent structural studies of the core machinery of the pathway, the protein kinases receptor-interacting protein kinase (RIPK)1 and RIPK3, and the terminal effector, the pseudokinase mixed lineage kinase domain-like protein (MLKL), in shaping our mechanistic understanding of necroptotic signaling. Structural studies have played a key role in establishing models that describe MLKL's transition from a dormant monomer to a killer oligomer and revealing important interspecies differences.
| Original language | English |
|---|---|
| Pages (from-to) | 53-63 |
| Number of pages | 11 |
| Journal | Trends in Biochemical Sciences |
| Volume | 44 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2019 |
| Externally published | Yes |
Keywords
- cell death
- DAMPs
- membrane pore
- programmed necrosis
- protein kinase
- pseudokinase
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver